admin@adna.org.au 03 8840 5072
IL17 and IL23 have largely superseded TNF inhibitors in psoriasis. However, they still play a significant role in rheumatology and gastroenterology.
Join Dr Andrew Östör (rheumatologist), Dr Emily Wright (gastroenterologist) and A/Prof Chris Baker(dermatologist) as they discuss where TNF inhibitors fit in the treatment options for psoriasis and explore TNF inhibitors and their competitors in inflammatory arthritis and inflammatory bowel disease (IBD).
We are excited to announce an upcoming opportunity to deepen your understanding of eczema care. On April 8th, 2025, from 7:00 pm to 8:00 pm AEST, Eczema Support Australia will host a FREE webinar "Eczema Care: Get the Facts from Experts." Featuring a panel of...
Date & Time Mar 19, 2025 19:00 Description The Skin Hospital is delighted to announce that Associate Professor Robyn Saw will presenton surgical updates in Stage III & IV melanoma treatment.Associate Professor Robyn Saw specialises in melanoma patient care...
Date & Time Mar 21, 2025 18:30 Description Associate Professor John Frew will present on American Academy of Dermatology (AAD) Conference Highlights on Friday 21 March at 6:30pm-7:30pm. This is a hybrid event, and attendance is available in-person or online via...
The MooGoo Post Graduate Scholarship applications are now OPEN, awarding up to $10,000 to help subsidise costs associated with Post-Graduate study. We have partnered with MooGoo Skin Care to bring you the 2025 MooGoo Postgraduate Cancer Nursing Scholarship. Launching...
